The present disclosure is concerned with borylated amidoximes useful in the synthesis of biologically relevant drug-like molecules, including functionalized oxadizole and quinazolinone derivatives. Also disclosed are methods of making borylated amidoximes, methods of making functionalized oxadiazole and quinazolinon...
Documents
Form FC-4-30092018-signed
Details of directors and key managerial personnel and their remuneration;-28092018
Details of Promoters , Directors and Key managerial personnel and changes therein since close of previous financial year;-28092018
Details of the meeting of the members or class thereof, board and its various committees along with attendance details;-28092018
Optional Attachment-(1)-28092018
Particulars of members and debenture holders along with changes therein since the close of previous financial year;-28092018
Optional Attachment-(2)-28092018
Form FC-2-11092018-signed
CERTIFICATE FOR CLOSURE OF PLACE OF BUSINESS-20180911
Optional Attachment-(3)-08092018
Optional Attachment-(2)-08092018
Optional Attachment-(1)-08092018
Copy of approval letter, if any;-08092018
-08092018
Details of directors and key managerial personnel and their remuneration;-01092018
Details of Promoters , Directors and Key managerial personnel and changes therein since close of previous financial year;-01092018
Details of the meeting of the members or class thereof, board and its various committees along with attendance details;-01092018
Particulars of members and debenture holders along with changes therein since the close of previous financial year;-01092018
-10082018
Copy of approval letter, if any;-10082018
Optional Attachment-(1)-10082018
Form FC-3-02072018_signed
Copy of balance sheet and profit and loss account duly authenticated under section 381(1)-27062018
Copy of latest consolidated financial statement of parent company -27062018
Form FC-3-17072017_signed
Copy of balance sheet and profit and loss account duly authenticated under section 381(1)-17072017
Copy of latest consolidated financial statement of parent company -17072017
Form FC-3-15072016_signed
Copy of latest consolidated financial statement of parent company -15072016
Copy of balance sheet and profit and loss account duly authenticated under section 381(1)-15072016